Growth Metrics

Solid Biosciences (SLDB) Non-Current Assets: 2017-2024

Historic Non-Current Assets for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $32.3 million.

  • Solid Biosciences' Non-Current Assets fell 11.13% to $32.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $32.3 million, marking a year-over-year decrease of 11.13%. This contributed to the annual value of $35.2 million for FY2023, which is 13.32% down from last year.
  • Latest data reveals that Solid Biosciences reported Non-Current Assets of $32.3 million as of Q3 2024, which was down 3.11% from $33.4 million recorded in Q2 2024.
  • Solid Biosciences' Non-Current Assets' 5-year high stood at $40.6 million during Q4 2022, with a 5-year trough of $8.9 million in Q1 2022.
  • For the 3-year period, Solid Biosciences' Non-Current Assets averaged around $33.9 million, with its median value being $36.4 million (2023).
  • Per our database at Business Quant, Solid Biosciences' Non-Current Assets crashed by 31.59% in 2021 and then soared by 335.67% in 2023.
  • Solid Biosciences' Non-Current Assets (Quarterly) stood at $12.3 million in 2020, then dropped by 20.38% to $9.8 million in 2021, then spiked by 315.79% to $40.6 million in 2022, then dropped by 13.32% to $35.2 million in 2023, then dropped by 11.13% to $32.3 million in 2024.
  • Its last three reported values are $32.3 million in Q3 2024, $33.4 million for Q2 2024, and $34.5 million during Q1 2024.